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Dact1, a Nutritionally Regulated Preadipocyte Gene,
Controls Adipogenesis by Coordinating the
Wnt/-Catenin Signaling Network
Claire Lagathu,1 Constantinos Christodoulides,1 Sam Virtue,1 William P. Cawthorn,1 Chiara Franzin,1
Wendy A. Kimber,1 Edoardo Dalla Nora,1 Mark Campbell,1 Gema Medina-Gomez,1
Benjamin N.R. Cheyette,2 Antonio J. Vidal-Puig,1 and Jaswinder K. Sethi1
OBJECTIVE—Wnt signaling inhibits adipogenesis, but its regu-
lation, physiological relevance, and molecular effectors are
poorly understood. Here, we identify the Wnt modulator Dap-
per1/Frodo1 (Dact1) as a new preadipocyte gene involved in the
regulation of murine and human adipogenesis.
RESEARCH DESIGN AND METHODS—Changes in Dact1
expression were investigated in three in vitro models of adipo-
genesis. In vitro gain- and loss-of-function studies were used to
investigate the mechanism of Dact1 action during adipogenesis.
The in vivo regulation of Dact1 and Wnt/-catenin signaling were
investigated in murine models of altered nutritional status, of
pharmacological stimulation of in vivo adipogenesis, and during
the development of dietary and genetic obesity.
RESULTS—Dact1 is a preadipocyte gene that decreases during
adipogenesis. However, Dact1 knockdown impairs adipogenesis
through activation of the Wnt/-catenin signaling pathway, and
this is reversed by treatment with the secreted Wnt antagonist,
secreted Frizzled-related protein 1 (Sfrp1). In contrast, constitu-
tive Dact1 overexpression promotes adipogenesis and confers
resistance to Wnt ligand-induced antiadipogenesis through in-
creased expression of endogenous Sfrps and reduced expression
of Wnts. In vivo, in white adipose tissue, Dact1 and Wnt/-
catenin signaling also exhibit coordinated expression profiles in
response to altered nutritional status, in response to pharmaco-
logical stimulation of in vivo adipogenesis, and during the
development of dietary and genetic obesity.
CONCLUSIONS—Dact1 regulates adipogenesis through coordi-
nated effects on gene expression that selectively alter intracellu-
lar and paracrine/autocrine components of the Wnt/-catenin
signaling pathway. These novel insights into the molecular
mechanisms controlling adipose tissue plasticity provide a func-
tional network with therapeutic potential against diseases, such
as obesity and associated metabolic disorders. Diabetes 58:
609–619, 2009
Dysregulated adipose function, as is observed inobesity, is associated with increased risk ofdeveloping diabetes, cardiovascular diseases,and some cancers. Recently, impaired adipose
tissue expandability/plasticity has been shown to be an
important factor linking obesity to its metabolic compli-
cations (1–4). This has led to the hypothesis that specific
regulatory mechanisms must exist to ensure that the
balance between preadipocyte recruitment and differenti-
ation tightly matches the storage demands imposed by
nutritional loads. Understanding the mechanisms that con-
trol when, how, and which preadipocytes enter the program
of differentiation may aid the development of rational thera-
peutic strategies to improve adipose tissue functionality and
lipid buffering capacity and thereby prevent and/or treat
obesity-associated metabolic disorders.
Adipocyte differentiation involves the sequential activa-
tion of a cascade of transcription factors that coordinate
the expression of genes responsible for the adipogenic
phenotype (5,6). Briefly, CCAAT/enhancer-binding protein
(C/EBP)  and  are rapidly and transiently induced in
response to adipogenic stimuli. This precedes the expres-
sion of the two adipogenic transcription factors, C/EBP
and peroxisome proliferator–activated receptor (PPAR).
These factors act synergistically to induce expression of
adipocyte-specific genes. Although in vitro adipogenesis
can be synchronously induced by exposure to a defined
adipogenic cocktail, in vivo adipose tissue expansion is
regulated by a combination of local and endocrine factors
that act to either stimulate or inhibit adipogenesis (7) in
response to demands for nutritional storage. In addition,
adipocyte growth is likely to be balanced with (and may
precede) recruitment of new adipocytes from the progen-
itor pool. In healthy individuals, tight regulation of these
processes is required to ensure that the appropriate num-
ber of adipocytes form and is sufficient (but not excessive)
to store nutritional surplus. As a highly conserved and
widely distributed intercellular signaling pathway, the Wnt
signaling network and its molecular components are good
candidates to contribute to this important regulated ho-
meostatic process.
The Wnt family of secreted glycoproteins function in
a paracrine and/or autocrine manner to influence cell
fate and development. Binding of specific Wnt proteins
to receptor/coreceptor complexes transduces intracel-
lular signals through either -catenin–dependent or
–independent pathways. Although both pathways may
be active in preadipocytes (8), it is the former that has
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been shown to potently inhibit adipogenesis both in
vitro and in vivo (9). The Wnt/-catenin signaling cas-
cade comprises specific cell surface Frizzled receptors
and LDL receptor–related protein 5 or 6 (LRP5/6) core-
ceptors, which on ligand binding transduce Wnt signals
via intracellular Dishevelled (Dvl) proteins, ultimately
leading to disassembly and inactivation of the -catenin
degradation complex (10,11). The resulting cytosolic
accumulation and nuclear translocation of -catenin
leads to transcriptional coactivation of the T-cell factor
(TCF)/lymphoid enhancer factor transcription factors.
Wnt/-catenin/TCF target genes include PPAR, inhibi-
tor of DNA binding 2 (Id2), CyclinD1, and c-Myc (my-
elocytomatosis oncogene). Some of these have been
shown to exhibit antiadipogenic actions (9,12,13).
In preadipocytes, constitutive activation of Wnt/-cate-
nin signaling leads to maintenance of the undifferentiated
state and prevents induction of C/EBP and PPAR (5,6).
In contrast, disruption of Wnt/-catenin signaling pro-
motes adipogenesis (9,12,14,15). These observations have
led to suggestions that Wnt proteins may act as a func-
tional “brake” during preadipocyte recruitment into the
differentiation program. Of the 19 possible Wnt ligands,
Wnt10b has been most clearly implicated as the endoge-
nous Wnt involved in regulating adipogenesis. Wnt10b is
expressed in both dividing and confluent preadipocytes,
but its expression decreases during adipogenesis preced-
ing the downregulation of intracellular -catenin. Further-
more, ectopic expression of Wnt10b activates Wnt/-
catenin signaling and potently inhibits adipogenesis
(16–18). Conversely, extracellular antagonists of Wnt/-
catenin signaling such as dickkopf homolog-1 and some of
the secreted Frizzled-related proteins (sFRP) have also
been shown to exert proadipogenic effects (14,15).
Although this evidence demonstrates Wnt/-catenin–
induced modulation of the adipogenic program, less is
known about the physiological regulation of Wnt/-catenin
signaling network in vivo. In this report, we identify
Dapper1/Frodo1 (Dact1) as an important preadipocyte
gene that controls adipocyte differentiation by regulating
the Wnt/-catenin signaling network. Previous reports
identified Dact1 as an evolutionarily conserved, Dvl-inter-
acting protein that modulates Wnt signals (19,20); how-
ever, its mechanism of action remains ambiguous (19–25).
In immortalized human embryonic kidney cells (HEK293)
and in some embryonic contexts, Dact1 appears to act as
an antagonist of Wnt/-catenin signaling (19,20,26). How-
ever, a positive function for Dact1 homologs in Wnt/-
catenin signaling has also been suggested by several
studies in other systems, particularly knockdown and low
overexpression studies in developing embryos (22,23).
Hence, it has been suggested that the function of Dact
family members is cell- and tissue-context–dependent
(23,26–28). Because adaptor or scaffold proteins are
likely to function by bringing together other signaling
components to form complexes favoring one biochem-
ical signaling cascade over another in a particular
cellular, physiological, or signaling context, it may not
be meaningful to categorize Dact proteins either as
general activators or inhibitors. Given this consider-
ation, it is important to note that before this study, the role
of Dact1 in adipogenesis was completely unexplored.
Here, we show that Dact1 acts to alter the Wnt/-catenin
signaling tone of preadipocytes through coordinated ef-
fects on both the efficiency of intracellular signal transduc-
tion pathway and by altering the expression profiles of
extracellular Wnt ligands and antagonists. The regulatory
network that we define here incorporates cell-specific
paracrine signals and is itself physiologically regulated,
because expression levels of key components Dact1,
Wnt10b, and Sfrp5 are all coordinately regulated in vivo in
adipose tissue by nutritional status, by proadipogenic
pharmacological stimulation, and during the development
of dietary and genetic obesity.
RESEARCH DESIGN AND METHODS
Tissue culture media, insulin, isobutylmethylxanthine, dexamethasone, Oil-
red-O, and puromycin were purchased from Sigma (St. Louis, MO). Tissue
culture sera were from HyClone (Logan, UT). Anti-Dvl1, anti-Dvl2, anti-Dvl3,
and anti–extracellular signal–regulated kinase-1/2 (-ERK1/2) antibodies were
from Santa Cruz Biotechnology (Santa Cruz, CA). The anti-Dact1 antibody was
from Orbigen (San Diego, CA). All antibodies were used according to the
manufacturer’s instructions. All horseradish peroxidase–conjugated second-
ary antibodies were from Cell Signaling Technology (Danvers, MA). Recom-
binant murine Wnt3a and human SFRP1 were from R&D Systems
(Minneapolis, MN).
Retroviral expression constructs and TCF4 reporter assay. Murine
Dact1 cDNA was excised from mouse-Dact1-pCMV (20) with BamH1-SnaB,
Klenow filled-in, and blunt-end–ligated into the SnaB1 site of the retroviral
expression vector pBabe-puro. Correct orientation was confirmed by at least
three different diagnostic digests. Stable knockdown of Dact1 was achieved
by retroviral expression of shRNA from the pSiren-RetroQ vector (Clontech,
Mountain View, CA). Custom oligonucleotides were identified using the
Dharmacon siDesign center (sequences available on request) and cloned into
pSiren-RetroQ according to the manufacturer’s instructions.
For TCF4 reporter assay, Dact1SH, CtrlSH, Dact1, and control 3T3-L1 cells
were grown to confluence, and Topflash promoter-reporter assays were
performed as previously described (15).
Animals. Animals were housed at a density of four animals per cage in a
temperature-controlled room (20–22°C) with 12-h light/dark cycles. The
effects of fasting and refeeding were studied using 8-week-old male SV129
mice (whole adipose tissue) and C57/B6 mice (tissue fractionation study). For
these studies, mice were deprived of chow for a 24-h period and either killed
or refed for a further period of 24 h. Mice were allowed ad libitum access to
water.
The effects of genetic obesity (ob/ob) were studied in tissues collected as
previously reported (29). The effects of long-term high-fat diet (16 weeks)
were studied in 7-month-old C57/B6 mice fed either standard laboratory chow
or high-fat diet (45% calories from fat; D12451; Research Diets, New Bruns-
wick, NJ) ad libitum from weaning. The short-term high-fat diet study was
performed on 16-week-old C57/B6 mice that had been fed either chow or
high-fat diet for either 3 or 28 days before they were killed. Adipose tissues
were collected from all mice at the same age. The effects of thiazolidinedione
(TZD) treatment were studied using male C57/B6 mice fed standard chow diet
supplemented with or without 10 ppm rosiglitazone (Avandia) for 3 weeks. All
animal protocols used in this study were approved by the UK Home Office and
the University of Cambridge.
Preadipocyte isolation, culture differentiation, and infection. Preadipo-
cyte isolation from human adipose tissue biopsies was performed as previ-
ously described (15). Cambridge Research Ethics Committee approval was
obtained, and all patients gave their informed consent. Murine primary
preadipocytes were isolated from epididymal white adipose tissue (WAT) of
6-week-old male C57/B6 mice as described previously (29).
3T3-L1 cells were cultured, differentiated into adipocytes, and stained for
Oil-red-O as described previously (12). Dact1 and control 3T3-L1 cell lines
were generated with the pBabe-Puro retroviral vector system, and Dact1SH
and CtrlSH 3T3-L1 cells were generated with the pSiren-RetroQ retroviral
vector system as described previously (12,30).
Protein extraction and Western blotting. Proteins were extracted from
cell monolayers as previously described (12). Proteins were electroblotted
nitrocellulose membrane (Amersham Biosciences). Specific proteins were
detected by incubation with the appropriate primary and horseradish peroxi-
dase–conjugated secondary antibodies. Immune complexes were detected by
enhanced chemiluminescence (Amersham Biosciences).
RNA isolation and quantitative RT-PCR. Total RNA was isolated from
cultured cells using an RNeasy kit (Qiagen, Crawley, U.K.), and mRNA
expression was analyzed by RT-PCR as described previously (12). The
sequences of the oligonucleotides used for primers and probes are available
on request.
Statistical analysis. Data from densitometrical analysis, luciferase assays,
and quantitative real-time PCR are presented as means  SE of at least three
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independent experiments. Statistical significance was determined with para-
metric (Student) or nonparametric (Mann–Whitney) tests, as appropriate
(*P  0.05, **P  0.01, and ***P  0.001).
RESULTS
Dact1 is decreased during adipogenesis and is re-
stricted to the preadipocyte-enriched fractions of
adipose tissue. Microarray expression profiling of human
preadipocyte differentiation revealed that Dact1 (DACT1)
is significantly downregulated at 6 and 48 h after induction
of adipogenesis. This downregulation was confirmed and
also observed during differentiation of primary preadipo-
cytes from both human and murine sources (Fig. 1A and
B) and was consistent with the enrichment of Dact1 in the
stroma-vascular fraction (SVF) when compared with ma-
ture adipocytes from WAT in both species (Fig. 1C and D).
In adult mice, Dact1 expression was also preferentially
expressed in WAT depots compared with brown adipose
tissue (BAT) (Fig. 1E). Dact1 expression in different
cellular models of fibroblasts and preadipocytes also cor-
related well with adipogenic potential and was barely
detectable in the BAT cells HIB1B (Fig. 1F).
As with primary preadipocyte cultures, Dact1 mRNA
was also found to decrease by 90% after 24 h following
adipogenic induction of the well-established 3T3-L1 prea-
dipocyte cell line. This profile preceded the decrease in
Dact1 protein in the same cells (Fig. 1G). However,
profiling the early immediate response to adipogenic stim-
uli revealed a rapid but transient upregulation of Dact1
limited to the first 6 h after adipogenic induction (Fig. 1H).
Dact1 is required for adipocyte differentiation of
3T3-L1 preadipocytes. The mRNA and protein profiles of
Dact1 suggest that it might be a preadipocyte marker gene
whose product contributes to the maintenance of the prea-
dipocyte phenotype. However, given that Dact1 can act in a
context-dependent manner to activate or inhibit Wnt/-cate-
nin signaling (19,20,22,23,26), it was possible that changes in
Dact1 levels reported here were functionally either pro- or
antiadipogenic. Thus, we performed gain- and loss-of-func-
tion experiments using four newly established 3T3-L1 prea-
dipocytes cell lines, engineered to constitutively express
Dact1 ShRNA (Dact1SH), control ShRNA (CtrlSH), Dact1
cDNA (Dact1), or empty vector control (EV).
In Dact1SH 3T3-L1 cells, endogenous expression of
Dact1mRNA was decreased by90% and remained at this
level throughout the differentiation process (Fig. 2A). In
contrast Dact1 3T3-L1 cells displayed a 10-fold increase of
Dact1 mRNA compared with EV 3T3-L1 cells (Fig. 2A).
These transcript levels were also reflected at the amount
of Dact1 protein (Fig. 2B). To evaluate the impact of
altered Dact1 levels on adipogenic potential, each cell line
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FIG. 1. DACT1 gene expression is downregulated in early adipogenesis and is found primarily the SVF of human and mouse adipose tissue. Human
DACT1 (A) and mouse Dact1 (B) mRNA levels were measured using real-time RT-PCR at the indicated time points after induction of
differentiation. **P < 0.01, ***P < 0.001 vs. time 0, n  7 experiments performed in duplicate. DACT1 and Dact1 mRNA levels were measured
in stroma-vascular cells (SVF) and mature adipocytes (MA) from human subcutaneous WAT (C) and mouse epididymal WAT (D). ***P < 0.001
vs. SVF, n  3 replicate experiments performed in duplicate. n  3 experiments performed in duplicate. E: Normalized Dact1 mRNA levels were
measured in epididydimal (epWAT), subcutaneous WAT (scWAT), and interscapular BAT of 10-week-old C57BL/6J. *P < 0.05, **P < 0.01, ***P <
0.001, n 3 experiments performed in duplicate. F: Dact1 mRNA levels, were measured in different cell types: fibroblast (NIH3T3), mesenchymal
stem cells (C3H10T1/2), white primary preadipocytes, white preadipocyte cell lines (3T3–L1 and 3T3–F442A), and brown preadipocyte cell line
(HIB1B), n  3–4 experiments performed in duplicate. G: Dact1 mRNA levels were measured at the indicated hours after induction (with MDI)
of 3T3–L1 preadipocyte differentiation. ***P < 0.001 vs. time 0, n  4 experiments performed in duplicate. Whole-cell protein lysates were
extracted at the indicated days of differentiation from 3T3 L1 cells and analyzed by immunoblotting. Representative immunoblots of Dact1 and
extracellular signal–related kinase (ERK)1/2 (loading control) from three separate experiments are shown.H:Dact1mRNA levels were measured
at the indicated hours after induction of 3T3–L1 preadipocytes with either control medium (serum) or MDI. *P < 0.05, **P < 0.01, and ***P <
0.001 vs. time 0 for MDI; †P < 0.05, ††P < 0.01, and †††P < 0.001 vs. serum, n  3–4 experiments performed in duplicate.
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was induced to differentiate and lipid accumulation visu-
alized with Oil Red-O staining. Knockdown of Dact1
(Dact1SH) almost completely blocked lipid accumulation
(Fig. 2C). This was consistent with the reduced expression
levels of the adipogenic markers C/EBP and PPAR in
these cells (Fig. 2D). Conversely, Dact1 3T3-L1 cells and
FIG. 2. Dact1 is required for adipocyte differentiation of 3T3–L1 preadipocytes. Preadipocytes were infected with a retrovirus carrying Dact1
ShRNA (Dact1SH), control ShRNA (CtrlSH), Dact1 (Dact1), or vector alone (EV). A: Dact1 mRNA levels, normalized to 18S rRNA levels, were
measured using real-time RT-PCR at the indicated hours of differentiation in Dact1SH- and CtrlSH-differentiated MDI and in Dact1 and EV cells
differentiated with DI. *P < 0.05 and ***P < 0.001 vs. CtrlSH or EV, n  3 experiments performed in duplicate. B: Whole-cell lysates were
extracted at 0 and day 8 days of differentiation from CtrlSH, Dact1SH, EV, and Dact1 cells and analyzed by immunoblotting. Representative
immunoblots of Dact1 and extracellular signal–related kinase (ERK)1/2 (loading control) from three separate experiments are shown. C:
Dact1SH and CtrlSH 3T3–L1 cells were differentiated with MDI, Dact1, and EV 3T3–L1 cells were differentiated with MDI or DI. Cells were stained
with Oil Red-O to visualize lipid droplets 8 days after induction, n  5. D: Ppar and Cebp mRNA levels, normalized to 18S rRNA levels, were
measured using real-time RT-PCR at the indicated hours of differentiation in Dact1SH and CtrlSH cells differentiated with MDI and in Dact1 and
EV cells differentiated with DI. At day 0, only PPAR mRNA was significantly altered in Dact1-SH preadipocytes. Neither PPAR not CEBP were
significantly altered in Dact vs. EV cells at time 0 h. *P < 0.05, *P < 0.05, **P < 0.01, and ***P < 0.001 vs. CtrlSH or EV, n  3 experiments
performed in duplicate. (Please see http://dx.doi.org/10.2337/db08-1180 for a high-quality digital representation of this figure.)
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EV 3T3-L1 cells differentiated to a similar extent when
induced with full induction cocktail (MDI). However,
induction with submaximal stimulation (DI) revealed that
Dact1 3T3-L1 cells have an increased propensity for lipid
accumulation (Fig. 2C). DI-treated Dact1 3T3-L1 cells also
showed increased expression of the adipogenic markers
PPAR and C/EBPwhen compared with similarly treated
EV 3T3-L1 cells (Fig. 2D). Taken together, these data
suggest that Dact1 is proadipogenic and is required for
adipogenesis.
Dact1 antagonizes Wnt/-catenin signaling in 3T3-L1
cells. To assess the function of Dact1 in Wnt/-catenin
signaling in 3T3-L1 preadipocytes, we first investigated
alterations in -catenin/TCF promoter activity (TOPflash)
in each cell line after adipogenic induction. Figure 3A
shows that -catenin/TCF promoter activity is reciprocally
related to the level of Dact1 expression in each cell line,
such that Dact1SH 3T3-L1 cells show significantly in-
creased reporter activity, whereas Dact1 3T3-L1 cells
show significantly reduced reporter activity. These results
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are further supported by parallel changes in the expres-
sion profiles of the endogenous Wnt target genes Cyclin
D1, Id2, and PPAR (Fig. 3B–D) in these cell lines. In
control cells, after maximal adipogenic induction by MDI
(CtrlSH cells) or submaximal induction by DI (EV cells),
Wnt target gene expression was transiently upregulated
between 0 and 24 h after induction (Fig. 3B–D). This
response was significantly blunted in Dact1 cells, whereas
Dact1SH cells maintained elevated target gene expression
levels throughout the time course of adipogenesis (Fig.
3B–D). These data suggest that Dact1 inhibits Wnt/-
catenin signaling in preadipocytes and also affects the
magnitude of their transcriptional response to adipogenic
treatment.
Dvl protein levels change dynamically during adipo-
genesis and are regulated by Dact1 in 3T3-L1 cells.
Dact1 was originally identified as a Dvl-interacting protein
(19,22) and has been reported in some contexts to antag-
onize Wnt signaling by inducing Dvl degradation (20). The
expression levels of Dvl family members have not previ-
ously been reported during adipogenesis nor has any study
systematically assessed the effect of Dact1 levels on all
three members of the Dvl family concurrently. Figure 4A
shows the protein expression profiles of all three members
of the Dvl family: Dvl1, Dvl2, and Dvl3 during adipogene-
sis in our in vitro models. Only Dvl2 and Dvl3 proteins are
detected in confluent preadipocytes. However, during the
adipogenic program each Dvl family member exhibits a
distinct expression profile. The protein expression profiles
closely parallel the corresponding mRNA profiles for each
Dvl gene (Fig. 4B–D), suggesting that changes in Dvl
protein levels are substantially regulated at the transcript
level.
To investigate whether altered Dact1 expression affects
Dvl protein levels during adipogenesis, we profiled Dvl
protein and mRNA expression in both Dact1SH and Dact1
3T3-L1 cells on days 0 and 8 after induction (Fig. 4B, D, F,
andH). Parallel changes were observed at both the protein
and RNA levels. Before adipogenic induction (day 0),
knockdown of Dact1 had no effect on levels of Dvl1 but
reduced levels of Dvl2 and increased levels of Dvl3. In
contrast, overexpression of Dact1 at day 0 had no signifi-
cant effect on Dvl1 or Dvl2 levels but reduced levels of
Dvl3. At day 8 after adipogenic treatment, the level of Dvl1
was significantly lower in Dact1SH 3T3-L1 cells but signif-
icantly higher in Dact1 3T3-L1 cells (Fig. 4B and D). In
contrast, at day 8, Dvl2 levels were minimal and unaffected
by Dact1 manipulation (Fig. 4B and F), whereas day 8 Dvl3
levels correlated reciprocally with that of Dact1, being
significantly higher in Dact1SH 3T3-L1 cells and lower in
Dact1 3T3-L1 cells (Fig. 4B and H). Hence, each of the Dvl
family members shows a distinct expression profile during
adipogenesis in 3T3-L1 cell lines and is likely to be
primarily regulated at the level of mRNA transcription.
Although levels of Dvl1 appear to correlate with extent of
adipocyte conversion, alterations in Dact1 levels does
impact directly on basal Dvl2 and Dvl3 expression.
Dact1 alters extracellular Wnt signals in preadipo-
cytes and in differentiating adipocytes. We next inves-
tigated whether extracellular components of the Wnt/-
catenin signaling cascade may be altered by changes in
Dact1. In Dact1SH 3T3-L1 cells before adipogenic induc-
tion, we observed an increase in mRNA levels of Wnt10b
and Wnt3a when compared with CtrlSH 3T3-L1 cells (Fig.
5A). Conversely, in Dact1-overexpressing 3T3-L1 cells,
Wnt10b and Wnt3a mRNA levels are decreased when
compared with EV 3T3-L1 cells (Fig. 5A). As expected,
after full induction of adipogenesis by MDI (CtrlSH) or
partial induction by DI (EV), Wnt10b levels fall signifi-
cantly by day 8 (Fig. 5A, top). However, in Dact1SH 3T3-L1
cells, levels of Wnt10b and Wnt3a remain higher than in
CtrlSH 3T3-L1 cells during adipogenic induction. Next, we
examined the mRNA expression profile of two closely
related secreted Wnt antagonists, Sfrp1 and Sfrp5. In
contrast to the decreasing expression of Wnt10b and
Wnt3a, Sfrp1 and Sfrp5 mRNA expression increased as
adipocytes differentiate (Fig. 5B). The fold increase was
proportional to the strength of adipogenic stimulation and
conversion.
To assess whether the effect of Dact1 on adipogenesis is
primarily due to altered production of extracellular Wnt
ligands and antagonists, we investigated the ability of
recombinant SFRP1 to reverse the antiadipogenic pheno-
type of Dact1SH 3T3-L1 cells. As shown in Fig. 5C,
Dact1SH 3T3-L1 cells treated with SFRP1 accumulate
more lipids than untreated Dact1SH 3T3-L1. SFRP1 acts
extracellularly by sequestering Wnt ligands, suggesting
that increased Wnt and decreased SFRP production are in
part responsible for the reduced adipogenic response of
Dact1SH cells.
Conversely, by treating Dact1 3T3-L1 cells with recom-
binant Wnt ligands, we assessed whether these cells were
more resistant to the antiadipogenic actions of extracellu-
lar Wnts. Treatment with recombinant Wnt3a practically
eliminated the ability of EV 3T3-L1 cells to accumulate
lipids, whereas Dact1 3T3-L1 cells accumulate lipid even
in the presence of Wnt3a. Together with our prior assays
of Wnt signaling, these data show that ectopically ex-
pressed Dact1 in 3T3-L1 cells inhibits the efficiency of
Wnt/-catenin signal transduction, thereby allowing these
cells to differentiate even in the presence of exogenous
Wnts. Taken together, our results suggest that changes in
Dact1 protein levels alter Wnt/-catenin signaling tone in
3T3-L1 cells through coordinated effects on both the
efficiency of intracellular signal transduction pathway and
by altering the expression profiles of extracellular Wnt
ligands and antagonists.
Dact1, Wnt10b, and Sfrp5 are all regulated by nutri-
tional status in vivo. We sought to determine whether
Dact1, Wnt10b, and Sfrp5 levels are regulated in vivo by
nutritional status. Fasting and/or refeeding experimental
conditions were selected as opposing physiological para-
digms with respect to acute fuel availability. In response to
fasting, the expression of Dact1, Wnt10b, and Sfrp5 were
all decreased in WAT. However, in response to refeeding,
the mRNA levels of all three genes were markedly in-
creased significantly beyond the levels found in the fed
state (Fig. 6). Interestingly, the expression of the Wnt/-
catenin target gene Ccnd1 was also markedly decreased
after fasting but remained low following refeeding (Fig.
6G). Figure 6E–H confirmed that these changes predomi-
nantly reflected alterations in SVFs (for Dact1 and
Wnt10b) and also in mature adipocytes (for Sfrp5). How-
ever, appreciable levels of Ccnd1 was found in both
fractions. Taken together, these data suggest that in re-
sponse to increased nutritional availability (refeeding),
adipose tissue undergoes dynamic changes in the expres-
sion of key components of the Wnt/-catenin signaling
pathway, including Dact1 in preadipocytes and Sfrp5 in
mature adipocytes. Furthermore, there is not only coordi-
nated upregulation of proadipogenic signals but also a
simultaneous upregulation of antiadipogenic Wnt-related
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signals. We speculate that the net effect of these is likely to
be important for titrating the actual target gene expression
and hence adipogenic potential of whole adipose tissue in
vivo.
Dact1, Wnt10b, and Sfrp5 are all regulated during
dietary and genetic models of obesity and by PPAR
activators. To further investigate the pathophysiological
regulation of Dact1, we measured the expression profiles
of Dact1, Wnt10b, and Sfrp5 in adipose tissue collected
from ob/ob mice. This is a mouse model of severe positive
energy balance characterized by marked hyperphagia and
early-onset obesity. By 5 weeks of age, ob/ob mice are in a
phase of rapid adipose accretion and are already signifi-
cantly heavier than their lean wild-type littermates (2). In
contrast, by 16 weeks of age the growth rate of ob/ob mice
has begun to plateau, a phase that coincides with these
animals being overtly obese and diabetic (29). Adipose
tissue taken from 5-week-old ob/ob mice show elevated
C
E
G
B
D
F
H
A
Dvl1
ERK1-2
Dvl3
Dvl2
***
**
*
**
*
D
vl
3 
m
R
N
A
/1
8S
 rR
N
A
0
100
200
300
400
Time (Hours post-MDI)
Time (Hours post-MDI)
Time (Hours post-MDI)
0 48 96 144 192
 0     6    12    24    48    96    192
******
***
***
**
D
vl
1 
m
R
N
A
/1
8S
 rR
N
A
0 48 96 144 192
400
0
100
200
300
*** *** ***
***
***
***
D
vl
2 
m
R
N
A
/1
8S
 rR
N
A
0
20
40
60
80
100
0 48 96 144 192
(Hours) 
Dvl1
ERK1-2
Dvl3
Dvl2
(Hours) 
0
100
200
300
400
400
0
100
200
300
D
vl
1 
m
R
N
A
/1
8S
 rR
N
A
D
vl
2 
m
R
N
A
/1
8S
 rR
N
A
D
vl
3 
m
R
N
A
/1
8S
 rR
N
A
***
NS
***
*
NS
**
**
NS
NS
NS
NS
*
day8day0 day8day0
0
100
200
300
400
400
0
100
200
300
0
40
80
120
160
0
40
80
120
160
day8day0
Ctrl
SH
Dact1
SH
Ctrl
SH
Dact1
SH EV Dact1 EV Dact1
Ctrl
SH
Dact1
SH
Ctrl
SH
Dact1
SH
EV Dact1 EV Dact1
day8day0 day8day0
Ctrl
SH
Dact1
SH
Ctrl
SH
Dact1
SH
EV Dact1 EV Dact1
day8day0 day8day0
Ctrl
SH
Dact1
SH
Ctrl
SH
Dact1
SH
EV Dact1 EV Dact1
day8day0
FIG. 4. Dact1 regulates the expression of Dvl in 3T3–L1 cells. A: Whole-cell lysates were extracted at indicated times after induction of 3T3–L1
adipogenesis. Representative immunoblots of Dvl1, Dvl2, Dvl3, and ERK1/2 (loading control) from three separate experiments are shown. Dvl1
(C), Dvl2 (E), and Dvl3 (G) mRNA levels, normalized to 18S rRNA levels, were measured using real-time RT-PCR at indicated times after
induction, n  3 experiments performed in duplicate. B: Whole-cell lysates were extracted at days 0 and 8 of differentiation from Dact1SH,
CtrlSH, EV, and Dact1 cells and analyzed by immunoblotting. Representative immunoblots of Dvl1, Dvl2, Dvl3, and ERK1/2 from three separate
experiments are shown. Dvl1 (D), Dvl2 (F), and Dvl3 (H) mRNA levels, normalized to 18S rRNA levels, were measured at days 0 and 8 of
differentiation in Dact1SH and CtrlSH cells differentiated with MDI and in differentiation in Dact1 and EV cells differentiated with DI. Complete
time course data for experiments presented in D, F, and H can be found in supplementary Fig. 1, available in the online appendix. *P< 0.05, **P<
0.01, and ***P < 0.001 vs. CrtlSH or EV, n  3 experiments performed in duplicate.
C. LAGATHU AND ASSOCIATES
DIABETES, VOL. 58, MARCH 2009 615
levels of proadipogenic Dact1 (Fig. 7A) and Sfrp5 (Fig. 7C)
and decreased levels of antiadipogenic Wnt10b (Fig. 7B),
resulting in a steady state that could be considered highly
proadipogenic. In contrast, Dact1 levels in the metaboli-
cally compromised 16-week-old ob/ob animals are signifi-
cantly lower than their age-matched wild-type littermates.
Interestingly, these older ob/ob mice also express reduced
Wnt10b, but their levels of Sfrp5 continued to rise (Fig. 7A,
D, and G).
We also investigated Dact1 expression in mice chal-
lenged with a short- and long-term high-fat diet. Similarly
to the young ob/ob mice, mice fed high-fat diet for 4 weeks
show significant increases in WAT mass compared with
chow-fed and age- and sex-matched littermates. Epididy-
mal WAT weights from 4-week high-fat diet– and chow-fed
mice were 1.01  0.14 g compared with 0.33  0.03 g,
respectively, P  0.002. At this time, adipose tissue levels
of proadipogenic Dact1 (Fig. 7B) and Sfrp5 (Fig. 7H) were
increased, whereas the levels of antiadipogenic Wnt10b
were decreased (Fig. 7E). Furthermore, in agreement with
the tendencies observed in older metabolically compro-
mised ob/ob mice, Dact1 and Wnt10b levels were reduced
(Fig. 7B–E), albeit to a lesser extent, in these wild-type
mice that have become obese and metabolically compro-
mised as a result of long-term high-fat diet (6 months).
We tested whether this Wnt-related network was mod-
ulated by pharmacological challenge with thiazolidinedio-
nes (TZDs), drugs known to promote adipogenesis and
improve insulin sensitivity. TZD treatment increased the
expression of adipogenic markers in adipose tissue (aP2
was increased by 1.63  0.14-fold, P  0.047). Strikingly,
this was accompanied by increases in Dact1 and Sfrp5
levels (Fig. 7C and I) and decreases in Wnt10b levels (Fig.
7F). Further studies on SVFs and adipocyte fractions
demonstrated that both Dact1 andWnt10b expression was
primarily altered in SVFs and preadipocytes. Furthermore,
TZD feeding significantly increased Sfrp5 and Fabp4 levels
primarily in adipocytes fractions (supplementary Fig. 2,
available in an online appendix at http://dx.doi.org/10.
2337/db08-1180). TZD-induced changes in Sfrp1 were the
same as those of Sfrp5 (data not shown). Taken together,
these findings suggest that Dact1 expression and key
extracellular components of the Wnt/-catenin signaling
network are coordinately regulated to facilitate adipose
tissue adaptation during anabolic states characterized by
active adipose tissue expansion. However, in predomi-
nantly catabolic states, such as insulin resistance and
diabetes, some aspects of this network may become
uncoupled.
DISCUSSION
Dact1 was first identified as an evolutionarily conserved,
Dvl-interacting protein (19,20); however, its mechanism of
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action and function remained ambiguous (19–23,25) and
was reported to be cell/tissue and context dependent
(23,26–28). Before this study, the presence and role of
Dact1 in adipogenesis/adipose tissue was unexplored.
Here, we demonstrate that Dact1 is primarily expressed in
both human and murine preadipocytes and in SVFs of
adipose tissue. Furthermore, Dact1 is downregulated dur-
ing adipogenic conversion of primary cultures and cell
lines. With this profile, Dact1 could be considered a
surrogate preadipocyte marker, however, we demonstrate
that its biological action contrasts with other previously
described “vanishing preadipocyte” genes (e.g., Gata2/3,
Pref1, and Wnt10b). Through both gain- and loss-of-
function approaches, we have shown that expression of
Dact1 confers proadipogenic potential and that its pres-
ence in the preadipocyte is required for efficient adipocyte
differentiation.
Our observations of the effects of Dact1 on adipogenesis
and on signaling in preadipocytes are most consistent with
its role as an antagonist of Wnt/-catenin signaling in this
tissue. This has only previously been demonstrated in
Xenopus embryos and mammalian embryonic fibroblasts
(19,20,26). Resolution of the discrepancies in the apparent
signaling function of Dact proteins may lie in our obser-
vations showing that manipulation of Dact1 in preadipo-
cytes elicits a differential and specific effect on the levels
of other proteins configuring a Wnt/-catenin signaling
network. This suggests that changes in Dact1 protein
concentrations have downstream effects on a whole net-
work of signaling proteins, which may contribute exquisite
modulation to the strength of Wnt/-catenin signaling
tone. It is noteworthy that some of the effects of Dact1
(i.e., altering Dvl levels) are strictly cell-autonomous,
whereas others (i.e., altering Wnt and sFRP levels) can
also be expected to affect signaling in neighboring cells.
The latter is likely to be highly relevant in vivo in an
otherwise cellularly heterogeneous adipose tissue, where
gene expression and differentiation state is likely to vary
significantly between neighboring cells. Dact1 may play a
significant role in determining not only the sensitivity of
the intracellular Wnt/-catenin pathway but also the
strength of the extracellular autocrine/paracrine Wnt sig-
nals to neighboring cells. We speculate that this type of
modulation, when regulated by nutrient availability, may
be the basis of a local self-regulating mechanism to titrate
the differentiation of an appropriate number of preadipo-
cytes to specific storage demands.
These studies also present several new components of
the Wnt/-catenin network not previously described in
adipose tissue and/or studied during adipogenesis. These
include four proteins expressed primarily in preadipocytes
(Dact1 Dvl2, Dvl3, and Wnt3a) and three expressed pri-
marily by mature adipocytes (Dvl1, sFRP1, and sFRP5).
Importantly, we also demonstrate that these molecules are
coordinately regulated in vivo in response to nutritional
and dietary challenges, in genetic forms of obesity and to
pharmacological agents typically producing adipose tissue
expansion and improving insulin sensitivity.
Given their intrinsic peculiarities, it is not unexpected
that our studies have revealed some differences between
the expression profiles obtained from in vivo and in vitro
models of adipogenic regulation. One important factor
that is worth considering is that the in vitro systems used
here represent a homogenous population of preadipocytes
that are simultaneously exposed to and synchronously
respond to defined adipogenic stimuli and/or genetic ma-
nipulation, thus allowing construction of detailed tempo-
ral profiles. In contrast, whole adipose tissues as used for
in vivo studies represent a heterogeneous population of
cell types each with distinct gene expression profiles and
sensitivities to nutritional and pathological cues and con-
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text-dependent feedback loops. These coupled with local
paracrine signals are likely to affect the dynamic balance
between mature adipocytes and preadipocytes. Further-
more, it is evident that adipose tissue expansion in vivo
does not involve the simultaneous recruitment of all
preadipocytes into the adipogenic program. Nonetheless,
it is clear from our findings that key determinants of
Wnt/-catenin signaling tone are regulated in response to
refeeding and that the sustained induction of Dact1 in
preadipocytes could be one mechanism facilitating, on one
hand, the preselection of preadipocytes for subsequent
differentiation and being the source of paracrine signals
that prevents the differentiation of more distal preadipo-
cytes, resulting in an appropriate titrated adipose tissue
expansion in response to nutritional status.
That being said, our in vitro observation that changes in
Dact1 levels lead to reciprocal changes in Wnt10b in
preadipocyte cell lines are recapitulated in adipose tissue
obtained from three in vivo models that reflect actively
expanding adipose tissue (short-term high-fat diet, young
ob/ob, and TZD-treated wild-type mice). Conversely, our
data also show that under conditions of insulin resistance
when adipogenesis and fat deposition are compromised
and fat accumulation plateaus, this network becomes
uncoupled, but Dact1 appears to be appropriately regu-
lated in the opposite direction. This suggests that Dact1
may act as a gate-keeper, facilitating the accurate adapta-
tion of adipose tissue expansion to storage requirements
based on nutritional and metabolic status.
In summary, we present evidence of a functional net-
work formed by Dact1, sFRP, and Wnt ligands that facili-
tates cross talk in adipose tissue between preadipocytes
and mature adipocytes, thereby ensuring appropriate titra-
tion of adipose tissue expansion in response to nutrient
availability. We speculate that dysregulation of this
network may be the pathogenic basis leading to an
altered balance between the processes of adipocyte
growth versus preadipocyte recruitment—ultimately
leading to a spectrum of adipose tissue cellularity
ranging from hypertrophy to hyperplasia. Similarly,
modulation of this network by targeting Dact1 may be of
therapeutic value to improve the metabolic efficiency of
the adipose tissue and prevent obesity-associated met-
abolic complications.
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